dexamethasone,rituximab,carboplatin,ifosfamide,etoposide,busulfan
Not Tagged
['lymsm', 'lymphoma', 'mds']
results of the international randomized phase 3 trial matrix/ielsg43 presented at #ash22 consolidation with #hdc-asct resulted in significantly better outcomes than non-myeloablative cit in primary cns lymphoma. #lymsm 
Independent, international experts in hematology and oncology, creating educational programmes on #lymsm and #mmsm in collaboration with COR2ED.